Acorda Therapeutics: Rebuilding the Spinal Cord Case Solution
Acorda is an early-stage life science start up with a promising product that's close to reaching the market (Phase III clinical trials). The firm is grappling with the best way to enlarge its portfolio of molecules to make the business sustainable. It faces classic in-licensing selections, what phase of growth, including what disorder indicator, how many molecules, and on what terms.
This is just an excerpt. This case is about TECHNOLOGY & OPERATIONS
PUBLICATION DATE: June 24, 2004
Related Case Solutions & Analyses:
Digital Extremes Ltd.
Tata Communications’ Acquisition of Tyco Global Network (A)
Iz-Lynn Chan at Far East Organization, Video
Global Business School Network
Student Plays Fantasy Hockey (B)
Patent & License Exchange: Enabling a Global IP Marketplace
Note on E-Mail and Privacy: U.S. Law and Company Policies
NaanDan and Jain: Leave This World Better Than You Found It
SATTVA eTECH: Challenges in Embedded New Product Development
Impacts of Security Climate on Employees’ Sharing of Security Advice and Troubleshooting: Empirical Networks
